CRH receptor antagonists: advances and prospective

Bibliography

• VALE W, SPIESS J, RIVIER C, RIVIER J: Characterization of a 41-residue ovine hypothalamicpeptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 213:1394–1397
   PubMed Web of Science ®Google Scholar
• DE SOUZA EB: Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology (1995) 20:789–819.
   PubMed Web of Science ®Google Scholar
• ••A comprehensive review of the CRH receptor subtypesdescribing in detail the anatomical location, physiology and biochemical characteristics.
   Google Scholar
• ORTH DN: Corticotropin-releasing hormone in humans. Endocr. Rev. (1992) 13:164–191.
   PubMed Web of Science ®Google Scholar
• •An important review on the physiology of CRH.
   Google Scholar
• WAND GS, EIPPER E: Effect of chronic secretogogueexposure on pro-ACTH/endorphin production and secretion in primary cultures of rat anterior pituitary. Endocrinology (1987)120:953–959.
   PubMed Web of Science ®Google Scholar
• WAND GS, MAY V, EIPPER BA: Acute and chronic effectsof CRF proACTH/endorphin production in primary cultures of rat anterior pituitary. Endocrinology (1988) 123:1153–1161.
   PubMedGoogle Scholar
• KOSTICH WA, CHEN A, SPERLE K, LARGENT BL:Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF-2-gamma receptor. Mol. Endocrinol. (1998) 12:1077–1083.
   PubMed Web of Science ®Google Scholar
• NICHOLSON WE, DECHERNEY GS, JACKSON RV, ORTHDN: Pituitary and hypothalamic hormones in normal and neoplastic adrenal medullae: biologically active corticotropin-releasing hormone and corticotropin. Regul. Pept. (1987) 18:173–178.
   PubMedGoogle Scholar
• YOON DJ, SKLAR C, DAVID R: Presence of immunoreac-tive corticotropin-releasing factor in rat testis. Endocri-nology (1988) 122:759–761.
   PubMedGoogle Scholar
• MASTORAKOS G, WEBSTER EL, FRIEDMAN TC,CHROUSOS GP: Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary. J. Clin. Invest. (1993) 92:961–968.
   PubMedGoogle Scholar
• NIEUWENHUYZEN KRUSEMAN AC, LINTON EA, ACKLAND J et al.: Heterogeneous immunocytochemical reactivities of oCRF-41-like material in the human hypothalamus, pituitary and gastrointestinal tract. Neuroendocrinology (1984) 38:212–216.
   PubMedGoogle Scholar
• SUDA T, TOMORI N, TOZAWA F et al.: Distribution andcharacterization of immunoreactive corticotropin-releasing factor in human tissues. J. Clin. Endocrinol. Metab. (1984) 59:861–866.
   PubMedGoogle Scholar
• PETRUSZ P, MERCHENTHALER I, MADERDRUT JL et al.:Corticotropin-releasing factor (CRF)-like immunore-activity in the vertebrate endocrine pancreas. Proc. Natl. Acad. Sci. USA (1983) 80:1721–1725.
   PubMed Web of Science ®Google Scholar
• CLIFTON VL, TELFER JF, THOMPSON AJ et al.: Corticotropin-releasinghormoneandproopiomelanocortin-derived peptides are present in human myometrium. J. Clin. Endocrinol. Metab. (1998) 83:3716–3721.
   PubMedGoogle Scholar
• DI BLASIO AM, PECORI GIRALDI F, VIGAN P, PETRAGLIAF, VIGNALI M, CAVAGNINI F: Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. J. Clin. Endocrinol. Metab. (1997) 82:1594–1597.
   PubMed Web of Science ®Google Scholar
• GRINO M, CHROUSOS GP, MARGIORIS AN: The cortico-tropin releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commun. (1987) 148:1208–1214.
   PubMed Web of Science ®Google Scholar
• STENZEL P, KESTERSON R, YEUNG W et al.: Identifica-tion of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. MoL Endocrinol. (1995) 9:637–645.
   PubMedGoogle Scholar
• SASAKI A, SATO S, MURAKAMI O et al.: Immunoreactive corticotropin-releasing hormone present in human plasma may be derived from both hypothalamic and extrahypothalamic sources. J. Clin. Endocrinol. Metab. (1987) 65:176–182.
   PubMedGoogle Scholar
• CUNNAH D, JESSOP DS, BESSER GM, REES LH: Measure-ment of circulating corticotrophin-releasing factor in man. J. Endocrinol. (1987) 113:123–127.
   PubMed Web of Science ®Google Scholar
• SASAKI A, SHINKAWA O, MARGIORIS AN et al.: Immuno-reactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. J. Clin. Endocrinol. Metab. (1987) 64:224–229.
   PubMed Web of Science ®Google Scholar
• CAMPBELL EA, LINTON EA, WOLFE CD et al.: Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol Metab. (1987) 64:1054–1059.
   PubMed Web of Science ®Google Scholar
• KALIN NH, SHELTON SE, BARKSDALE CM: Behavioral and physiologic effects of CRH administered to infant primates undergoing maternal separation. Neuropsy-chopharmacology (1989) 2:97–104.
   PubMed Web of Science ®Google Scholar
• SUOMI SJ: Early determinants of behaviour: evidence from primate studies. Br. Med. Bull. (1997) 53:170–84.
   PubMed Web of Science ®Google Scholar
• ••The author is an authority on the field of early life stressorsin non-human primates and its relation to HPA axis abnormalities.
   Google Scholar
• COPLAN JD, ANDREWS MW, ROSENBLUM LA et al.: Persis-tent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc. Natl. Acad. Sci. USA (1996) 93:1619–1623.
   PubMed Web of Science ®Google Scholar
• LADD CO, OWENS MJ, NEMEROFF CB: Persistent changes in corticotropin-releasing factorneuronal systems induced by maternal deprivation. Endocri-nology (1996) 137:1212–1218.
   PubMed Web of Science ®Google Scholar
• BRITTON KT, LEE G, DANA R, RISCH SC, KOOB GF: Activating and `anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci. (1986) 39:1281–1286.
   PubMed Web of Science ®Google Scholar
• TIMPL P, SPANAGEL R, SILLABER I et al.: Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nature Genet. (1998) 19:162–166.
   PubMed Web of Science ®Google Scholar
• WENINGER SC, DUNN AJ, MUGLIA LJ et al.: Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc. Natl Acad. Sci. USA (1999) 96:8283–8288.
   PubMed Web of Science ®Google Scholar
• STENZEL-POORE M, VALE WW, RIVIER C: Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology (1993) 132:1313.
   PubMed Web of Science ®Google Scholar
• GOLD PW, GOODWIN FK, CHROUSOS GP: Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1). N Engl. J. Med. (1988) 319:348–353.
   PubMed Web of Science ®Google Scholar
• •Emphasizes the link between stress and depressive disorders. An elegant review.
   Google Scholar
• PLOTSKY PM, OWENS MJ, NEMEROFF CB: Psychoneuro- endocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North. Am. (1998) 21:293–307
   PubMed Web of Science ®Google Scholar
• •An excellent review about the HPA axis abnormalities observed in major depression. An excellent start for newcomers on the field.
   Google Scholar
• NEMEROFF CB, OWENS MJ, BISSETTE G, ANDORN AC,STANLEY M: Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry (1988) 45:577–579.
   PubMed Web of Science ®Google Scholar
• BREMNER JD, LICINIO J, DARNELL A et al.: Elevated CSFcorticotropin-releasing factor concentrations in post-traumatic stress disorder. Am. J. Psychiatry (1997) 154:624–629.
   PubMed Web of Science ®Google Scholar
• ALTEMUS M, SWEDO SE, LEONARD HL et al.: Changes incerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Arch. Gen. Psychiatry (1994) 51:794–803.
   PubMed Web of Science ®Google Scholar
• ROY-BYRNE PP, UHDE TW, POST RM, GALLUCCI W, CHROUSOS GP, GOLD PW: The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am. J. Psychiatry (1986) 143:896–899.
   PubMed Web of Science ®Google Scholar
• HOLSBOER F: The rationale for corticotropin-releasinghormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. (1999) 33:181–214.
   PubMed Web of Science ®Google Scholar
• RIVIER JE, KIRBY DA, LAHRICHI SL et al.. Constrainedcorticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat. J. Med. Chem. (1999) 16:3175–3182.
   Google Scholar
• LUNDKVIST J, CHAI Z, TEHERANIAN R et al.: A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits amdolytic-like activity. Eur. J. Pharmacol. (1996) 309:195–200.
   PubMed Web of Science ®Google Scholar
• DEAK T, NGUYEN KT, EHRLICH AL et al: The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology (1999) 140:79–86
   PubMed Web of Science ®Google Scholar
• GRIEBEL G, PERRAULT G, SANGER DJ: Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Ber) (1998) 138:55–66.
   PubMed Web of Science ®Google Scholar
• HABIB et al. Proceedings of the 81 Endocrine Society Annual Meeting, San Diego, CA, June 1999.
   Google Scholar
• WONG ML, WEBSTER EL, SPOKES H et al: Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Life ScL (1999) 65:PL53–58.
   PubMedGoogle Scholar
• BORNSTEIN SR, WEBSTER EL, TORPY DJ et al.: Chroniceffects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regula-tion. Endocrinology (1998) 139:1546–1555.
   PubMed Web of Science ®Google Scholar
• WAND GS: Alcohol and the HPA axis. The Endocrinolo-gists (1999) 9: 333–341.
   Google Scholar
• PIAZZA PV, DEROCHE V, ROUGE-PONT F et al.. Behavioral and biological factors associated with individual vulnerability to psychostimulant abuse. NIDA Res. Monogr. (1998) 169:105–133.
   PubMedGoogle Scholar
• TIMPL P, SPANAGEL R, SILLABER I et al.: Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nature Genet. (1998) 19:162–166.
   PubMed Web of Science ®Google Scholar
• MCCARTHY JR, HEINRICHS SC, GRIGORIADIS DE: Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Curr. Pharm. Des. (1999) 5:289–315.
   PubMed Web of Science ®Google Scholar
• ••Perhaps the most comprehensive and recent review on nonpeptide CRH 1 antagonists.
   Google Scholar
• RODRIGUEZ DE FONSECA F, CARRERA MRA, NAVARRO M, KOOB GF, WEISS F: Activation of corticotropin-releasing factor in the limbic system during cannabi-noid withdrawal. Science (1997) 276:2050–2054.
   PubMedGoogle Scholar
• BROADBEAR JH, WINGER G, WOODS JH: Cocaine-reinforced responding in rhesus monkeys: pharma-cological attenuation of the hypothalamic-pituitary-adrenal axis response. J. Pharmacol. Exp. Ther. (1999) 290:1347–1355.
   PubMed Web of Science ®Google Scholar
• CHAN EC, FALCONER J, MADSEN G et al.: A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep. Endocrinology (1998) 139:3357–3360.
   PubMed Web of Science ®Google Scholar
• MCLEAN M, SMITH R: Corticotropin-releasing hormone in human pregnancy and parturition. Trends in Endocrinology and Metabolism (1999) 10:174–178.
   PubMed Web of Science ®Google Scholar
• BARAM TZ, CHALMERS DT, CHEN C, KOUTSOUKOS Y, DE SOUZA EB: The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res. (1997) 770:89–95.
   PubMed Web of Science ®Google Scholar
• SINGH LK, BOUCHER W, PANG X et al.: Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J. Pharmacol. Exp. Ther. (1999) 288:1349–1356.
   PubMed Web of Science ®Google Scholar
• ELENKOV IJ, WEBSTER EL, TORPY DJ, CHROUSOS GP: Stress, corticotropin releasing hormone, glucocorti-coids, and the immune/inflammatory response: acute and chronic effects. Ann. NY Acad. Sci. (1999) 876:1-11; discussion 11–13.
   Google Scholar
• ••Important aspects of the putative role of CRH as an immunemodulator are discussed.
   Google Scholar
• WEBSTER EL, LEWIS DB, TORPY DJ, ZACHMAN EK, RICE KC, CHROUSOS GP: In vivo and in vitro characteriza-tion of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology (1996) 137:5747–5750.
   PubMed Web of Science ®Google Scholar
• WOODS RJ, DAVID J, BAIGENT S et al.: Elevated levels of corticotrophin-releasing factor binding protein in the blood of patients suffering from arthritis and septicaemia and the presence of novel ligands in synovial fluid. Br. J. Rheumatol. (1996) 35:120.
   PubMedGoogle Scholar
• ENGLER D, REDEI E, KOLA I: The corticotropin-release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Endocr. Rev. (1999) 20:460–500.
   PubMedGoogle Scholar